Product Images Norepinephrine Bitartrate In Sodium Chloride

This is a description of a medication called "Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection", which is a high alert medication. It comes in a 250 mL single-dose container with prescription-only availability for intravenous use only. Each mL contains 16 micrograms of norepinephrine base, 0.9% sodium chloride, hydrochloric acid, sodium hydroxide, and water for injection. It is recommended to check for minute leaks and solution clarity before administration, and any unused portion should be discarded. The recommended dosage is to be determined by prescription. The medication should be stored between 20°C to 25°C (68°F to 77°F) and protected from freezing. The product should be used within 7 days of removal from overwrap. Its manufacturer is WG Critical Care, LLC, located in Paramus, NJ. The Lot Exp is BHBIUSIORKD.*

This is a medication called Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, with an NDC of 44567-641-01 and a volume of 250mL. The recommended dosage should be checked based on prescribing information. Each mL contains 32 micrograms of norepinephrine base and comes as a single-dose container. The medication must be used within 7 days of removal from an overwrap and should be stored at 20°C to 25°C (68°F to 77°F). The product also contains hydrochloric acid, sodium hydroxide, water for injection, and 0.9% sodium chloride. It should not be used in series connections or with supplementary medication. Any minute leaks or impairments should result in discarding the medication. The product is manufactured in Switzerland and distributed by WG Critical Care in Paramus, NJ.*

This is a description of a medication labeled as "A High Alert Medication A". It comes in a 250mL single-dose container with the NDC code 44567-642-01. The medication is norepinephrine bitartrate in 0.9% sodium chloride injection containing 16mg per 250mL (or 64 mcg per mL) for intravenous use only. Each mL of the solution includes 64 micrograms of norepinephrine base, 0.9% sodium chloride, hydrochloric acid, sodium hydroxide, and water for injection. The recommended dosage should be followed, as per prescribing information. The pH level of the solution is 3-4. The medication should not be used in series connections or supplementary medications added. The solution should be checked for minute leaks and solution clarity, and if leaks or impaired sterility are found, it should be discarded. Unused portions should also be discarded, and the product should be used within 7 days of removal from the overwrap. The medication should be stored at 20°C to 25°C (68°F to 77°F) and protected from freezing. This medication is manufactured in Switzerland by WG Critical Care, LLC. The Lot number is available on the label.*